In the realm of cattle health, managing conditions like bovine respiratory disease (BRD) and acute mastitis, which often involve pyrexia (fever) and inflammation, is critical for herd productivity and welfare. Flunixin Meglumine stands out as a powerful non-steroidal anti-inflammatory drug (NSAID) that is highly effective in controlling these symptoms. As a dedicated supplier in China, NINGBO INNO PHARMCHEM CO.,LTD. provides a premium grade of Flunixin Meglumine, a vital pharmaceutical intermediate for the veterinary industry.

The efficacy of Flunixin Meglumine in cattle lies in its ability to target inflammation and reduce fever. It is indicated for the control of pyrexia associated with BRD and endotoxemia, as well as for controlling inflammation in endotoxemia. For cattle owners and veterinarians, understanding the specific flunixin meglumine uses for cattle ensures optimal therapeutic outcomes. The drug's anti-inflammatory action helps to alleviate the discomfort and physiological stress caused by these conditions.

The flunixin meglumine dosage for cattle varies depending on the condition being treated. For pyrexia and inflammation associated with BRD and endotoxemia, a dosage of 1.1 to 2.2 mg/kg is recommended, administered intravenously. For acute bovine mastitis, a single intravenous dose of 2.2 mg/kg is typically used. It is imperative that all treatments are administered under the guidance of a licensed veterinarian to ensure safety and efficacy. NINGBO INNO PHARMCHEM CO.,LTD. supports the veterinary community by supplying a consistent and high-purity product.

Choosing a reliable manufacturer in China for your pharmaceutical needs is crucial. NINGBO INNO PHARMCHEM CO.,LTD. is committed to providing top-tier Flunixin Meglumine, supporting the health and productivity of cattle operations worldwide. The strategic use of this veterinary NSAID contributes significantly to disease management and animal welfare in the agricultural sector.